tirzepatide cardiovascular outcome trial SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity tirzepatide cardiovascular outcomes trial results

Any potential neuroprotective benefits remain speculative and require dedicated clinical trials

If a model includes tissue remodeling, inflammatory context, and structural repair at the same time, a single compound may only illuminate one slice of the response

Tian F, Huang S, Xu W, Chen L, Su J, Ni H, et al

Consult a health professional before using if you have a health condition

By reducing appetite, stabilizing blood sugar, and supporting healthy eating habits, it helps patients achieve meaningful, long-term results

Typically, people qualify for this treatment if they have a body mass index (BMI) of 27 or higher along with weight-related health issues, or a BMI of 30 or more